Patricia Guijarro

Suggest Changes
Learn More
OBJECTIVE To describe the frequency of drug combinations (substrate-substrate or substrate-inhibitor) with the potential to interfere with the CYP2D6 metabolic pathway in patients receiving(More)
  • 1